Under construction – not a live service
Sign in
Taking people in IsraelNo phase

Tracking Arm Movement in Daily Life After Stroke

Monitors daily arm movement of adults with stroke and relates it to recovery measures.

Plain-language title generated from the registry record
Registry title: Upper Limb Movement Quality Following Stroke

Key facts

Where
Ofakim, IsraelSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Source: NCT06497881, who can take part

Where in Israel

  • Adi-Negev Nahalat EranOfakim, IsraelTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Adi Negev-Nahalat Eran
Trial code
NCT06497881
Record updated
3 October 2025
Original description
The aim of this study is to monitor the daily upper limb movement of persons with stroke, and to relate these quantities to measures of recovery and impairment.Read full original descriptionShow less

Monitoring Post Stroke Upper-Limb Movement in The Wild

The aim of this study is to monitor the daily upper limb movement of persons with stroke, and to relate these quantities to measures of recovery and impairment.

Inclusion: >18 years of age; Independent in all activities of daily living before the stroke; In- and out-patients at Adi-Negev Nahalat-Eran rehabilitation center; Medically stable; Able to provide informed consent.

Exclusion: The presence of any degenerative neurological condition, neuropathy, myopathy or Polio that are not secondary to stroke, excluding diabetic related changes; Traumatic brain injury and/or extra-cerebral hemorrhage; Significant psychiatric condition, including alcoholism and drug abuse; Any severe orthopedic condition (such as amputation or severe pain that limits activity) or chronic pain syndrome.

ClinicalTrials.gov NCT06497881